Health
Newly approved drugs in Canada lack key pediatric drug information – News-Medical.Net
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
Reviewed by Emily Henderson, B.Sc.Sep 1 2020
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
This absence of pediatric information perpetuates “off-label” drug use which could be dangerous for this vulnerable population, say the authors. They add that Canadian regulatory mechanisms are needed to ensure submission of pediatric data by manufacturers when use …
-
Business15 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business17 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business14 hours agoHere’s what analysts expect for the BHP share price in the coming year